Irving based drug development company, DelSite has filed for Chapter 7 bankruptcy. One of the causes is said to be failure to raise additional money to develop a bird flu vaccine.
The company claimed $1 million to $10 million in assets and $10 million to $50 million in liabilities. They have been closing down facilities and laying off employees over the last year.
If you are considering filing for bankruptcy, contact the Galveston bankruptcy attorneys of Gipson, Norman & Root at 409-765-6000.
